These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31444237)

  • 1. Arylamine
    Li P; Butcher NJ; Minchin RF
    Mol Pharmacol; 2019 Nov; 96(5):573-579. PubMed ID: 31444237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockout of human arylamine N-acetyltransferase 1 (NAT1) in MDA-MB-231 breast cancer cells leads to increased reserve capacity, maximum mitochondrial capacity, and glycolytic reserve capacity.
    Carlisle SM; Trainor PJ; Doll MA; Stepp MW; Klinge CM; Hein DW
    Mol Carcinog; 2018 Nov; 57(11):1458-1466. PubMed ID: 29964355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and small molecule inhibition of arylamine N-acetyltransferase 1 reduces anchorage-independent growth in human breast cancer cell line MDA-MB-231.
    Stepp MW; Doll MA; Carlisle SM; States JC; Hein DW
    Mol Carcinog; 2018 Apr; 57(4):549-558. PubMed ID: 29315819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimodal distribution of arylamine N-acetyltransferase 1 mRNA in breast cancer tumors: association with overall survival and drug resistance.
    Minchin RF; Butcher NJ
    BMC Genomics; 2018 Jul; 19(1):513. PubMed ID: 29969986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNAi-mediated knock-down of arylamine N-acetyltransferase-1 expression induces E-cadherin up-regulation and cell-cell contact growth inhibition.
    Tiang JM; Butcher NJ; Cullinane C; Humbert PO; Minchin RF
    PLoS One; 2011 Feb; 6(2):e17031. PubMed ID: 21347396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arylamine N-acetyltransferase 1 protects against reactive oxygen species during glucose starvation: Role in the regulation of p53 stability.
    Wang L; Minchin RF; Butcher NJ
    PLoS One; 2018; 13(3):e0193560. PubMed ID: 29518119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of human arylamine N-acetyltransferase I regulates mitochondrial function by inhibition of the pyruvate dehydrogenase complex.
    Wang L; Minchin RF; Essebier PJ; Butcher NJ
    Int J Biochem Cell Biol; 2019 May; 110():84-90. PubMed ID: 30836144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High N-Acetyltransferase 1 Expression Is Associated with Estrogen Receptor Expression in Breast Tumors, but Is not Under Direct Regulation by Estradiol, 5
    Zhang X; Carlisle SM; Doll MA; Martin RCG; States JC; Klinge CM; Hein DW
    J Pharmacol Exp Ther; 2018 Apr; 365(1):84-93. PubMed ID: 29339455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines.
    Tiang JM; Butcher NJ; Minchin RF
    Cancer Med; 2015 Apr; 4(4):565-74. PubMed ID: 25627111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9 knockout of human arylamine N-acetyltransferase 1 in MDA-MB-231 breast cancer cells suggests a role in cellular metabolism.
    Carlisle SM; Trainor PJ; Hong KU; Doll MA; Hein DW
    Sci Rep; 2020 Jun; 10(1):9804. PubMed ID: 32555504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arylamine N-acetyltransferase 1 deficiency inhibits drug-induced cell death in breast cancer cells: switch from cytochrome C-dependent apoptosis to necroptosis.
    McAleese CE; Butcher NJ; Minchin RF
    Breast Cancer Res Treat; 2022 Oct; 195(3):223-236. PubMed ID: 35918499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer.
    Endo Y; Yamashita H; Takahashi S; Sato S; Yoshimoto N; Asano T; Hato Y; Dong Y; Fujii Y; Toyama T
    BMC Cancer; 2014 Dec; 14():990. PubMed ID: 25528056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of estrogen receptor 1 and N‑acetyltransferase gene expression in normal breast tissue, primary breast tumors, and established breast cancer cell lines.
    Carlisle SM; Hein DW
    Int J Oncol; 2018 Aug; 53(2):694-702. PubMed ID: 29901116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arylamine N-acetyltransferase 1 expression in breast cancer cell lines: a potential marker in estrogen receptor-positive tumors.
    Wakefield L; Robinson J; Long H; Ibbitt JC; Cooke S; Hurst HC; Sim E
    Genes Chromosomes Cancer; 2008 Feb; 47(2):118-26. PubMed ID: 17973251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibitors increase human arylamine N-acetyltransferase-1 expression in human tumor cells.
    Paterson S; Sin KL; Tiang JM; Minchin RF; Butcher NJ
    Drug Metab Dispos; 2011 Jan; 39(1):77-82. PubMed ID: 20870783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic organization of human arylamine N-acetyltransferase Type I reveals alternative promoters that generate different 5'-UTR splice variants with altered translational activities.
    Butcher NJ; Arulpragasam A; Goh HL; Davey T; Minchin RF
    Biochem J; 2005 Apr; 387(Pt 1):119-27. PubMed ID: 15487985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect arylamine N-acetyltransferase 1 on morphology, adhesion, migration, and invasion of MDA-MB-231 cells: role of matrix metalloproteinases and integrin αV.
    Li P; Butcher NJ; Minchin RF
    Cell Adh Migr; 2020 Dec; 14(1):1-11. PubMed ID: 31910058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arylamine N-acetyltransferase 1 gene regulation by androgens requires a conserved heat shock element for heat shock factor-1.
    Butcher NJ; Minchin RF
    Carcinogenesis; 2010 May; 31(5):820-6. PubMed ID: 20176657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of arylamine acetyltransferase Nat3 gene knockout on N-acetylation in the mouse.
    Sugamori KS; Brenneman D; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
    Drug Metab Dispos; 2007 Jul; 35(7):1064-70. PubMed ID: 17403913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of arylamine N-acetyltransferase 1 in MDA-MB-231 human breast cancer cells reduces primary and secondary tumor growth in vivo with no significant effects on metastasis.
    Doll MA; Ray AR; Salazar-González RA; Shah PP; Vega AA; Sears SM; Krueger AM; Hong KU; Beverly LJ; Hein DW
    Mol Carcinog; 2022 May; 61(5):481-493. PubMed ID: 35133049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.